How CRISPR-Enabled Gene Editing Could Change Our World: A Huntington's Disease Case Study
Because Huntington’s disease is caused by a single gene mutation, it is a prime early target for clinical trials involving somatic cell genome editing.
Françoise Baylis
Professor emerita at Dalhousie University. Bioethicist and author of Altered Genes, Twisted Truth and Altered: CRISPR and the Ethics of Human Genome Editing.